The 2020 presidential election on Nov. 3 is quickly approaching, and Drugwatch researched President Donald J. Trump and former Vice President Joe Biden’s stances on three issues important to voters.
Key issues include: health care, coverage for pre-existing conditions and prescription drug prices.
Drugwatch does not take a public stance on candidates. We gathered this nonpartisan information directly from official White House statements and Biden’s official campaign website. Neither campaign responded to Drugwatch’s request for a statement in time for article publication.
About 68 percent of all voters ranked health care as “very important” to their vote in the 2020 election, according to a 2020 poll by the Pew Research Center.
The candidates have different plans for providing health care coverage but agree on points such as health care tax credits, affordability and greater flexibility and choice.
In a December 2019 statement, the president said he would continue to work to provide access to high-quality health care at an affordable price. President Trump intends to repeal and replace the Affordable Care Act and does not support Medicare for All.
“The Trump Administration is working on realistic solutions to provide Americans with the options and control they want, the affordability they need, the ease they expect, and the quality they deserve, rather than forcing a government takeover of the healthcare system,” former White House Press Secretary Sarah Sanders said in an April 2019 statement.
President Trump supports the American Health Care Act (AHCA) of 2017, a bill that proposes protection for pre-existing conditions, reduced costs of health care, greater choice and flexibility, extra funding for states that “waive certain Obamacare rules” and lower taxes for Americans, according to a White House statement.
Former Vice President Joe Biden wants to protect and build on the Affordable Care Act.
While he does not support Medicare for All, he promises “a public health insurance option like Medicare,” according to Biden’s campaign site.
“Instead of starting from scratch and getting rid of private insurance, he has a plan to build on the Affordable Care Act by giving Americans more choice, reducing health care costs, and making our health care system less complex to navigate,” the site says about the Biden Plan.
The Biden Plan includes plans to protect coverage for pre-existing conditions, increase tax credits for working Americans, expand coverage, stop “surprise billing” for providers not in-network and defend health care protections for all, regardless of gender, gender identity or sexual orientation.
According to a November 2018 poll conducted by the American Cancer Society, about 90 percent of voters said they would be “concerned” if coverage for pre-existing conditions was no longer required. This issue remains a top concern with voters across party affiliations.
Both candidates have pledged to protect health plan coverage for pre-existing conditions.
Affordability of prescription drugs is one of the most important issues for voters. A poll commissioned by The Campaign for Sustainable Rx Pricing (CSRxP) found that 90 percent of voters said prescription drug prices are a “very important” or “somewhat important” issue facing Americans.
Both candidates plan to reduce the cost of prescription drugs. They agree that Americans should have more access to generics and be able to buy less expensive prescription drugs from other countries such as Canada.
“Since the day I took office, I have made reducing drug prices one of my highest priorities,” President Trump said in a July 24, 2020, White House statement.
According to the statement, the president signed four executive orders directed at lowering prescription drug costs.
Trump’s four executive orders:
“The Biden Plan will put a stop to runaway drug prices and the profiteering of the drug industry,” according to Biden’s campaign site.
The Biden Plan promises to reduce drug prices by:
Drugwatch.com writers follow rigorous sourcing guidelines and cite only trustworthy sources of information, including peer-reviewed journals, court records, academic organizations, highly regarded nonprofit organizations, government reports and interviews with qualified experts. Review our editorial policy to learn more about our process for producing accurate, current and balanced content.
Calling this number connects you with one of Drugwatch's trusted legal partners. A law firm representative will review your case for free.
Drugwatch's sponsors support the organization’s mission to keep people safe from dangerous drugs and medical devices. For more information, visit our sponsors page.(888) 645-1617